# FDA recall D-1141-2015

> **AstraZeneca Pharmaceuticals LP** · Class II · drug recall initiated 2015-06-10.

## Product

NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.

## Reason for recall

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿  XR tablets.

## Distribution

Nationwide to wholesalers for further distribution at the retail level.

## Key facts

- **Recall number:** D-1141-2015
- **Recalling firm:** AstraZeneca Pharmaceuticals LP
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-06-10
- **Report date:** 2015-06-24
- **Termination date:** 2016-09-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilmington, DE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1141-2015

## Citation

> AI Analytics. FDA recall D-1141-2015. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1141-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*